Initial release
Initial implementation of the Weusten model for estimating risk-day equivalents (infectious window period equivalent) for NAT-screened blood products.
Initial implementation of the Weusten model for estimating risk-day equivalents (infectious window period equivalent) for NAT-screened blood products.